Emerging roles of ATF2 and the dynamic AP1 network in cancer (original) (raw)

• Lee, W., Mitchell, P. & Tjian, R. Purified transcription factor AP1 interacts with TPA-inducible enhancer elements. Cell 49, 741–752 (1987).
  Article CAS PubMed Google Scholar
• Angel, P. et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49, 729–739 (1987).
  Article CAS PubMed Google Scholar
• Wisdom, R. AP1: One switch for many signals. Exp. Cell Res. 253, 180–185 (1999).
  Article CAS PubMed Google Scholar
• Eferl, R. & Wagner, E. F. AP1: a double-edged sword in tumorigenesis. Nature Rev. Cancer 3, 859–868 (2003).
  Article CAS Google Scholar
• Angel, P. & Karin, M. The role of Jun, Fos and the AP1 complex in cell-proliferation and transformation. Biochem. Biophys. Acta 1072, 129–157 (1991).
  CAS PubMed Google Scholar
• Vlahopoulos, S. A. et al. The role of ATF-2 in oncogenesis. Bioessays 30, 314–327 (2008).
  Article CAS PubMed Google Scholar
• Maki, Y., Bos, C., Davis, C., Starbuck, M. & Vogt, P. Avian sarcoma virus 17 carries the jun oncogene. Proc. Natl Acad. Sci. USA 84, 2848–2852 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Vogt, P. K. Jun, the oncoprotein. Oncogene 20, 2365–2377 (2001).
  Article CAS PubMed Google Scholar
• Eferl, R. et al. Functions of c-Jun in liver and heart development. J. Cell Biol. 145, 1049–1061 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Mechta-Grigoriou, F., Gerald, D. & Yaniv, M. The mammalian Jun proteins: redundancy and specificity. Oncogene 20, 2378–2389 (2001).
  Article CAS PubMed Google Scholar
• Bakiri, L., Lallemand, D., Bossy-Wetzel, E. & Yaniv, M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J. 19, 2056–2068 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Mariani, O. et al. JUN Oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell 11, 361–374 (2007).
  Article CAS PubMed Google Scholar
• Shaulian, E. & Karin, M. AP1 in cell proliferation and survival. Oncogene 20, 2390–2400 (2001).
  Article CAS PubMed Google Scholar
• Angel, P., Hattori, K., Smeal, T. & Karin, M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP1. Cell 55, 875–885 (1988).
  Article CAS PubMed Google Scholar
• van Dam, H. & Castellazzi, M. Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene 20, 2453–2464 (2001).
  Article CAS PubMed Google Scholar
• Sng, J. C. G., Taniura, H. & Yoneda, Y. A tale of early response genes. Biol. Pharm. Bull. 27, 606–612 (2004).
  Article CAS PubMed Google Scholar
• Whitmarsh, A. J. & Davis, R. J. Regulation of transcription factor function by phosphorylation. Cell. Mol. Life Sci. 57, 1172–1183 (2000).
  Article CAS PubMed Google Scholar
• Katabami, M. et al. Cyclin A is a c-Jun target gene and is necessary for c-Jun-induced anchorage-independent growth in RAT1a cells. J. Biol. Chem. 280, 16728–16738 (2005).
  Article CAS PubMed Google Scholar
• Weitzman, J. B., Fiette, L., Matsuo, K. & Yaniv, M. JunD protects cells from p53-dependent senescence and apoptosis. Mol. Cell 6, 1109–1119 (2000).
  Article CAS PubMed Google Scholar
• Schreiber, M. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13, 607–619 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Ameyar-Zazoua, M. et al. AP1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene. Oncogene 24, 2298–306 (2005).
  Article CAS PubMed Google Scholar
• Deng, T. & Karin, M. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev. 7, 479–490 (1993).
  Article CAS PubMed Google Scholar
• Aggarwal, B. B. & Gehlot, P. Inflammation and cancer: how friendly is the relationship for cancer patients? Curr. Opin. Pharmacol. 9, 351–369 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Passegue, E. & Wagner, E. F. JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression. EMBO J. 19, 2969–2979 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ryseck, R. P., Hirai, S. I., Yaniv, M. & Bravo, R. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature 334, 535–537 (1988).
  Article CAS PubMed Google Scholar
• Mayo, M. W., Steelman, L. S. & McCubrey, J. A. Phorbol esters support the proliferation of a hematopoietic cell line by upregulating c-jun expression. Oncogene 9, 1999–2008 (1994).
  CAS PubMed Google Scholar
• Zhang, Y. et al. Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model. BMC Cancer 7, 145 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Jin, X. et al. Blockade of AP1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma. Mol. Carcinog. 46, 901–911 (2007).
  Article CAS PubMed Google Scholar
• Shimizu, Y. et al. Growth inhibition of non-small cell lung cancer cells by AP1 blockade using a cJun dominant-negative mutant. Br. J. Cancer 98, 915–922 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Shen, Q. et al. The AP1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Oncogene 27, 366–377 (2008).
  Article CAS PubMed Google Scholar
• Suto, R. et al. Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer. Gene Therapy 11, 187–193 (2004).
  Article CAS PubMed Google Scholar
• Passegue, E., Jochum, W., Behrens, A., Ricci, R. & Wagner, E. F. JunB can substitute for Jun in mouse development and cell proliferation. Nature Genet. 30, 158–166 (2002).
  Article CAS PubMed Google Scholar
• Agarwal, S. K. et al. Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. Proc. Natl Acad. Sci. USA 100, 10770–10775 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Laine, A. & Ronai, Z. Ubiquitin chains in the ladder of MAPK signaling. Sci. STKE 281, re5 (2005).
  Google Scholar
• Dérijard, B. et al. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025–1037 (1994).
  Article PubMed Google Scholar
• Sabapathy, K. et al. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol. Cell 15, 713–725 (2004).
  Article CAS PubMed Google Scholar
• Sabapathy, K. & Wagner, E. F. JNK2: a negative regulator of cellular proliferation. Cell Cycle 3, 1520–1523 (2004).
  Article CAS PubMed Google Scholar
• Lively, T. N., Ferguson, H. A., Galasinski, S. K., Seto, A. G. & Goodrich, J. A. c-Jun binds the N terminus of Human TAFII250 to derepress RNA polymerase II transcription in vitro. J. Biol. Chem. 276, 25582–25588 (2001).
  Article CAS PubMed Google Scholar
• Franklin, C. C., McCulloch, A. V. & Kraft, A. S. In vitro association between the Jun protein family and the general transcription factors, TBP and TFIIB. Biochem. J. 305, 967–974 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Karin, M., Liu, Z. G. & Zandi, E. AP1 function and regulation. Curr. Opin. Cell Biol. 9, 240–246 (1997).
  Article CAS PubMed Google Scholar
• Weiss, C. et al. JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J. 22, 3686–3695 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kallunki, T., Deng, T., Hibi, M. & Karin, M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87, 929–939 (1996).
  Article CAS PubMed Google Scholar
• Gallo, A. et al. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation. Oncogene 21, 6434–6445 (2002).
  Article CAS PubMed Google Scholar
• Lopez-Bergami, P. et al. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11, 447–460 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Morton, S., Davis, R. J., McLaren, A. & Cohen, P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 22, 3876–3886 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bhoumik, A. & Ronai, Z. ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities. Cell Cycle 7, 2341–2345 (2008).
  Article CAS PubMed Google Scholar
• Wei, W., Jin, J., Schlisio, S., Harper, J. W. & Kaelin, W. G. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8, 25–33 (2005).
  Article CAS PubMed Google Scholar
• Nateri, A. S., Riera-Sans, L., Da Costa, C. & Behrens, A. The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 303, 1374–1378 (2004).
  Article CAS PubMed Google Scholar
• Davis, R. J. Signal transduction by the JNK group of MAP kinases. Cell 103, 239–252 (2000).
  Article CAS PubMed Google Scholar
• Fuchs, S. Y., Dolan, L., Davis, R. J. & Ronai, Z. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 13, 1531–1535 (1996).
  CAS PubMed Google Scholar
• Bossis, G. et al. Down-regulation of c-Fos/c-Jun AP1 dimer activity by sumoylation. Mol. Cell. Biol. 25, 6964–6979 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Cheng, J., Perkins, N. D. & Yeh, E. T. Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases. J. Biol. Chem. 280, 14492–14498 (2005).
  Article CAS PubMed Google Scholar
• Farras, R., Bossis, G., Andermarcher, E., Jariel-Encontre, I. & Piechaczyk, M. Mechanisms of delivery of ubiquitylated proteins to the proteasome: new target for anti-cancer therapy? Crit. Rev. Oncol. Hematol. 54, 31–51 (2005).
  Article PubMed Google Scholar
• Garaude, J. et al. SUMOylation regulates the transcriptional activity of JunB in T lymphocytes. J. Immunol. 180, 5983–5990 (2008).
  Article CAS PubMed Google Scholar
• Musti, A. M., Treier, M., Peverali, F. A. & Bohmann, D. Differential regulation of c-Jun and JunD by ubiquitin-dependent protein degradation. Biol. Chem. 377, 619–624 (1996).
  CAS PubMed Google Scholar
• Tulchinsky, E. Fos family members: regulation, structure and role in oncogenic transformation. Histol. Histopathol. 15, 921–928 (2000).
  CAS PubMed Google Scholar
• Halazonetis, T. D., Georgopoulos, K., Greenberg, M. E. & Leder, P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 55, 917–924 (1988).
  Article CAS PubMed Google Scholar
• Greenberg, M. E. & Ziff, E. B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311, 433–438 (1984).
  Article CAS PubMed Google Scholar
• Kovary, K. & Bravo, R. The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11, 4466–4472 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Adiseshaiah, P., Peddakama, S., Zhang, Q., Kalvakolanu, D. V. & Reddy, S. P. Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements. Oncogene 24, 4193–4205 (2005).
  Article CAS PubMed Google Scholar
• Basbous, J., Jariel-Encontre, I., Gomard, T., Bossis, G. & Piechaczyk, M. Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer? Biochimie 90, 296–305 (2008).
  Article CAS PubMed Google Scholar
• Pellegrino, M. J. & Stork, P. J. Sustained activation of extracellular signal-regulated kinase by nerve growth factor regulates c-fos protein stabilization and transactivation in PC12 cells. J. Neurochem. 99, 1480–1493 (2006).
  Article CAS PubMed Google Scholar
• Tanos, T. et al. Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP1 response to UV light. J. Biol. Chem. 280, 18842–18852 (2005).
  Article CAS PubMed Google Scholar
• Basbous, J., Chalbos, D., Hipskind, R., Jariel-Encontre, I. & Piechaczyk, M. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol. Cell. Biol. 27, 3936–3950 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Malnou, C. E. et al. Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic. J. Biol. Chem. 282, 31046–31059 (2007).
  Article CAS PubMed Google Scholar
• Hai, T. & Hartman, M. G. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273, 1–11 (2001).
  Article CAS PubMed Google Scholar
• Bhoumik, A., Lopez-Bergami, P. & Ronai, Z. ATF2 on the double — activating transcription factor and DNA damage response protein. Pigment Cell Res. 20, 498–506 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Breitwieser, W. et al. Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes Dev. 21, 2069–2082 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Takeda, J. et al. Expression of the CRE-BP1 transcriptional regulator binding to the cyclic AMP response element in central nervous system, regenerating liver, and human tumors. Oncogene 6, 1009–1014 (1991).
  CAS PubMed Google Scholar
• Kim, H. S., Choi, E. S., Shin, J. A., Jang, Y. K. & Park, S. D. Regulation of Swi6/HP1-dependent heterochromatin assembly by cooperation of components of the mitogen-activated protein kinase pathway and a histone deacetylase Clr6. J. Biol. Chem. 279, 42850–42859 (2004).
  Article CAS PubMed Google Scholar
• Bruhat, A. et al. ATF2 is required for amino acid-regulated transcription by orchestrating specific histone acetylation. Nucleic Acids Res. 35, 1312–1321 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Agelopoulos, M. & Thanos, D. Epigenetic determination of a cell-specific gene expression program by ATF-2 and the histone variant macroH2A. EMBO J. 25, 4843–4853 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Maekawa, T. et al. Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J. Biol. Chem. 274, 17813–17819 (1999).
  Article CAS PubMed Google Scholar
• Papassava, P. et al. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors. Cancer Res. 64, 8573–8584 (2004).
  Article CAS PubMed Google Scholar
• Zoumpourlis, V. et al. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Oncogene 19, 4011–4021 (2000).
  Article CAS PubMed Google Scholar
• Woo, I. S., Kohno, T., Inoue, K., Ishii, S. & Yokota, J. Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer. Int. J. Oncol. 20, 527–531 (2002).
  CAS PubMed Google Scholar
• Maekawa, T. et al. Reduced levels of ATF-2 predispose mice to mammary tumors. Mol. Cell. Biol. 27, 1730–1744 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Song, H., Ki, S. H., Kim, S. G. & Moon, A. Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res. 66, 10487–10496 (2006).
  Article CAS PubMed Google Scholar
• Reimold, A. M. et al. Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 379, 262–265 (1996).
  Article CAS PubMed Google Scholar
• Ozawa, K., Sudo, T., Soeda, E., Yoshida, M. C. & Ishii, S. Assignment of the human CREB2 (CRE-BP1) gene to 2q32. Genomics 10, 1103–1104 (1991).
  Article CAS PubMed Google Scholar
• Landschulz, W. H., Johnson, P. F. & McKnight, S. L. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240, 1759–1764 (1988).
  Article CAS PubMed Google Scholar
• Liu, H. et al. Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localization. EMBO J. 25, 1058–1069 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Li, X. Y. & Green, M. R. Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. Genes Dev. 10, 517–527 (1996).
  Article CAS PubMed Google Scholar
• Ouwens, D. M. et al. Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J. 21, 3782–3793 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Gupta, S., Campbell, D., Derijard, B. & Davis, R. J. Transcription factor ATF2: regulation by the JNK signal transduction pathway. Science 267, 389–393 (1995).
  Article CAS PubMed Google Scholar
• Firestein, R. & Feuerstein, N. Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9. Implication of the ubiquitin/proteasome pathway in regulation of ATF2 in T cells. J. Biol. Chem. 273, 5892–5902 (1998).
  Article CAS PubMed Google Scholar
• Fuchs, S. Y. & Ronai, Z. Ubiquitination and degradation of ATF2 are dimerization dependent. Mol. Cell. Biol. 19, 3289–3298 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Fuchs, S. Y., Tappin, I. & Ronai, Z. Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation. J. Biol. Chem. 275, 12560–12564 (2000).
  Article CAS PubMed Google Scholar
• Bhoumik, A. et al. ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. Mol. Cell 18, 577–587 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Yamasaki, T., Takahashi, A., Pan, J., Yamaguchi, N. & Yokoyama, K. K. Phosphorylation of activation transcription factor-2 at serine 121 by protein kinase C controls c-Jun-mediated activation of transcription. J. Biol. Chem. 284, 8567–8581 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hai, T. W., Liu, F., Coukos, W. J. & Green, M. R. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 3, 2083–2090 (1989).
  Article CAS PubMed Google Scholar
• Kerppola, T. K. & Curran, T. Selective DNA bending by a variety of bZIP proteins. Mol. Cell. Biol. 13, 5479–5489 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Ronai, Z. et al. ATF2 confers radiation resistance to human melanoma cells. Oncogene 16, 523–531 (1998).
  Article CAS PubMed Google Scholar
• Ma, Q. et al. Activating transcription factor 2 controls Bcl-2 promoter activity in growth plate chondrocytes. J. Cell Biochem. 101, 477–487 (2007).
  Article CAS PubMed Google Scholar
• Zenz, R. et al. c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev. Cell 4, 879–889 (2003).
  Article CAS PubMed Google Scholar
• Shaulian, E. & Karin, M. AP1 as a regulator of cell life and death. Nature Cell Biol. 4, E131–E136 (2002).
  Article CAS PubMed Google Scholar
• Johnson, R., Spiegelman, B., Hanahan, D. & Wisdom, R. Cellular transformation and malignancy induced by ras require c-jun. Mol. Cell. Biol. 16, 4504–4511 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Behrens, A., Jochum, W., Sibilia, M. & Wagner, E. F. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 19, 2657–2663 (2000).
  Article CAS PubMed Google Scholar
• Binetruy, B., Smeal, T. & Karin, M. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351, 122–127 (1991).
  Article CAS PubMed Google Scholar
• Talotta, F. et al. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP1 activity in RAS transformation. Oncogene 28, 73–84 (2009).
  Article CAS PubMed Google Scholar
• Milde-Langosch, K. The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer 41, 2449–2461 (2005).
  Article CAS PubMed Google Scholar
• Bergers, G., Graninger, P., Braselmann, S., Wrighton, C. & Busslinger, M. Transcriptional activation of the fra-1 gene by AP1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol. 15, 3748–3758 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Jenuwein, T. & Muller, R. Structure-function analysis of fos protein: a single amino acid change activates the immortalizing potential of v-fos. Cell 48, 647–657 (1987).
  Article CAS PubMed Google Scholar
• Sunters, A., McCluskey, J. & Grigoriadis, A. E. Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation. Dev. Genet. 22, 386–397 (1998).
  Article CAS PubMed Google Scholar
• Ledwith, B. J., Manam, S., Kraynak, A. R., Nichols, W. W. & Bradley, M. O. Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene. Mol. Cell. Biol. 10, 1545–1555 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Olive, M. et al. A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J. Biol. Chem. 272, 18586–18594 (1997).
  Article CAS PubMed Google Scholar
• Jochum, W. et al. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nature Med. 6, 980–984 (2000).
  Article CAS PubMed Google Scholar
• Mikula, M. et al. The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. Oncogene 22, 6725–6738 (2003).
  Article CAS PubMed Google Scholar
• Graves, M. L., Zhou, L., MacDonald, G., Mueller, C. R. & Roskelley, C. D. Regulation of the BRCA1 promoter in ovarian surface epithelial cells and ovarian carcinoma cells. FEBS Lett. 581, 1825–1833 (2007).
  Article CAS PubMed Google Scholar
• Abbas, S. et al. Preclinical studies of celastrol and acetyl isogambogic acid in melanoma. Clin. Cancer Res. 13, 6769–6778 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Bhoumik, A., Jones, N. & Ronai, Z. Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity. Proc. Natl Acad. Sci. USA 101, 4222–4227 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Vale-Cruz, D. S., Ma, Q., Syme, J. & LuValle, P. A. Activating transcription factor-2 affects skeletal growth by modulating pRb gene expression. Mech. Dev. 125, 843–856 (2008).
  Article CAS PubMed Google Scholar
• Nakamura, T. et al. Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site. Exp. Cell Res. 216, 422–430 (1995).
  Article CAS PubMed Google Scholar
• Beier, F., Taylor, A. C. & LuValle, P. Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes. J. Biol. Chem. 275, 12948–12953 (2000).
  Article CAS PubMed Google Scholar
• Bhoumik, A. et al. Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc. Natl Acad. Sci. USA 105, 1674–1679 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Maekawa, T. et al. ATF-2 controls transcription of Maspin and GADD45α genes independently from p53 to suppress mammary tumors. Oncogene 27, 1045–1054 (2008).
  Article CAS PubMed Google Scholar
• Chen, S. Y. et al. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma. J. Dermatol. Sci. 51, 210–215 (2008).
  Article CAS PubMed Google Scholar
• Knippen, S. et al. Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas. Anticancer Res. 29, 183–189 (2009).
  CAS PubMed Google Scholar
• Lewis, J. S. et al. Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2. Oncol. Res. 15, 113–128 (2005).
  Article CAS PubMed Google Scholar
• Berger, A. J. et al. Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival. Cancer Res. 63, 8103–8107 (2003).
  CAS PubMed Google Scholar
• Deng, X. et al. Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression. Cancer Res. 68, 9663–9670 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Daury, L. et al. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts. Oncogene 20, 7998–8008 (2001).
  Article CAS PubMed Google Scholar
• Chu, M., Guo, J. & Chen, C. Y. Long-term exposure to nicotine, via ras pathway, induces cyclin D1 to stimulate G1 cell cycle transition. J. Biol. Chem. 280, 6369–6379 (2005).
  Article CAS PubMed Google Scholar
• Manna, S. K. et al. Long term environmental tobacco smoke activates nuclear transcription factor-κB, activator protein-1 and stress responsive kinases in mouse brain. Biochem. Pharmacol. 71, 1602–1609 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Heintz, N. H., Janssen, Y. M. & Mossman, B. T. Persistent induction of c-fos and c-jun expression by asbestos. Proc. Natl Acad. Sci. USA 90, 3299–3303 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Janssen, Y. M., Heintz, N. H., Marsh, J. P., Borm, P. J. & Mossman, B. T. Induction of c-fos and c-jun proto-oncogenes in target cells of the lung and pleura by carcinogenic fibers. Am. J. Respir. Cell. Mol. Biol. 11, 522–530 (1994).
  Article CAS PubMed Google Scholar
• Fried, U., Kotarsky, K. & Alling, C. Chronic ethanol exposure enhances activating protein-1 transcriptional activity in human neuroblastoma cells. Alcohol 24, 189–195 (2001).
  Article CAS PubMed Google Scholar
• Matthews, C. P. et al. Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis. Cancer Res. 67, 2430–2438 (2007).
  Article CAS PubMed Google Scholar
• Young, M. R. et al. Transgenic mice demonstrate AP1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl Acad. Sci. USA 96, 9827–9832 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Astruc, M. E., Chabret, C., Bali, P., Gagne, D. & Pons, M. Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: involvement of the estrogen receptor. Endocrinology 136, 824–832 (1995).
  Article CAS PubMed Google Scholar
• Brozovic, A. et al. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. Int. J. Cancer 112, 974–985 (2004).
  Article CAS PubMed Google Scholar
• Ozanne, B. W., Spence, H. J., McGarry, L. C. & Hennigan, R. F. Transcription factors control invasion: AP1 the first among equals. Oncogene 26, 1–10 (2007).
  Article CAS PubMed Google Scholar
• Maeno, K. et al. Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers. Oncogene 25, 271–277 (2005).
  Article CAS Google Scholar
• Shiratsuchi, T., Ishibashi, H. & Shirasuna, K. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP1 decoy in human squamous cell carcinoma cell lines. J. Cell Physiol. 193, 340–348 (2002).
  Article CAS PubMed Google Scholar
• Katiyar, S., Jiao, X., Wagner, E., Lisanti, M. P. & Pestell, R. G. Somatic excision demonstrates that c-Jun induces cellular migration and invasion through induction of stem cell factor. Mol. Cell. Biol. 27, 1356–1369 (2007).
  Article CAS PubMed Google Scholar
• Hommura, F. et al. HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for c-Jun-induced anchorage-independent growth in Rat1a cells. Mol. Cancer Res. 2, 305–314 (2004).
  CAS PubMed Google Scholar
• Kinoshita, I. et al. Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: Increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth. Oncogene 22, 2710–2722 (2003).
  Article CAS PubMed Google Scholar
• Jooss, K. U. & Muller, R. Deregulation of genes encoding microfilament-associated proteins during Fos-induced morphological transformation. Oncogene 10, 603–608 (1995).
  CAS PubMed Google Scholar
• Westermarck, J. et al. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2. Cancer Res. 60, 7156–7162 (2000).
  CAS PubMed Google Scholar
• Reichmann, E. et al. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71, 1103–1116 (1992).
  Article CAS PubMed Google Scholar
• Belguise, K., Kersual, N., Galtier, F. & Chalbos, D. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24, 1434–1444 (2005).
  Article CAS PubMed Google Scholar
• Ramos-Nino, M. E., Scapoli, L., Martinelli, M., Land, S. & Mossman, B. T. Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma. Cancer Res. 63, 3539–3545 (2003).
  CAS PubMed Google Scholar
• Chen, S. Y. et al. Concordant overexpression of phosphorylated ATF2 and STAT3 in extramammary Paget's disease. J. Cutan. Pathol. 36, 402–408 (2009).
  Article PubMed Google Scholar
• Jean, D. & Bar-Eli, M. Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family. Mol. Cell Biochem. 212, 19–28 (2000).
  Article CAS PubMed Google Scholar
• Vleugel, M. M., Greijer, A. E., Bos, R., van der Wall, E. & van Diest, P. J. c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Hum. Pathol. 37, 668–674 (2006).
  Article CAS PubMed Google Scholar
• Zhang, G. et al. Effect of deoxyribzymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J. Natl Cancer Inst. 96, 683–696 (2004).
  Article CAS PubMed Google Scholar
• Zhang, G. et al. Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression. Oncogene 25, 7260–7266 (2006).
  Article CAS PubMed Google Scholar
• Bowden, G. T., Schneider, B., Domann, R. & Kulesz-Martin, M. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis. Cancer Res. 54, 1882–1885 (1994).
  Google Scholar
• Toft, D. J., Rosenberg, S. B., Bergers, G., Volpert, O. & Linzer, D. I. H. Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression. Proc. Natl Acad. Sci. USA 98, 13055–13059 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Ming, J., Zhang, Q., Qiu, X. & Wang, E. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer. Eur. J. Cancer 45, 866–873 (2009).
  Article CAS PubMed Google Scholar
• Ham, J. et al. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14, 927–939 (1995).
  Article CAS PubMed Google Scholar
• Wang, N. et al. c-Jun triggers apoptosis in human vascular endothelial cells. Circ. Res. 85, 387–393 (1999).
  Article CAS PubMed Google Scholar
• Podar, K. et al. Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma. Cancer Res. 67, 1680–1688 (2007).
  Article CAS PubMed Google Scholar
• Bossy-Wetzel, E., Bakiri, L. & Yaniv, M. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16, 1695–1709 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Hettinger, K. et al. c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ. 14, 218–229 (2006).
  Article PubMed CAS Google Scholar
• Eferl, R. et al. Liver Tumor development: c-Jun antagonizes the proapoptotic activity of p53. Cell 112, 181–192 (2003).
  Article CAS PubMed Google Scholar
• Stepniak, E. et al. c-Jun/AP1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev. 20, 2306–2314 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kalra, N. & Kumar, V. c-Fos is a mediator of the c-myc-induced apoptotic signaling in serum-deprived hepatoma cells via the p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 279, 25313–25319 (2004).
  Article CAS PubMed Google Scholar
• Siegmund, D. et al. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway. J. Biol. Chem. 276, 32585–32590 (2001).
  Article CAS PubMed Google Scholar
• Kustikova, O. et al. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol. Cell. Biol. 18, 7095–7105 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Shirsat, N. V. & Shaikh, S. A. Overexpression of the immediate early gene fra-1 inhibits proliferation, induces apoptosis, and reduces tumourigenicity of c6 glioma cells. Exp. Cell Res. 291, 91–100 (2003).
  Article CAS PubMed Google Scholar
• Jochum, W., Passegue, E. & Wagner, E. F. AP1 in mouse development and tumorigenesis. Oncogene 20, 2401–2412 (2001).
  Article CAS PubMed Google Scholar
• Leppa, S., Eriksson, M., Saffrich, R., Ansorge, W. & Bohmann, D. Complex functions of AP1 transcription factors in differentiation and survival of PC12 cells. Mol. Cell. Biol. 21, 4369–4378 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Behrens, A., Sibilia, M. & Wagner, E. F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nature Genet. 21, 326–329 (1999).
  Article CAS PubMed Google Scholar
• Yuan, Z. et al. Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis. Mol. Cell. Biol. (2009).
• Li, W., Zhang, X. & Olumi, A. F. MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIPL . Cancer Res. 67, 2247–2255 (2007).
  Article CAS PubMed Google Scholar
• Adunyah, S. E., Chander, R., Barner, V. K., Cooper, R. S. & Copper, R. S. Regulation of c-jun mRNA expression by hydroxyurea in human K562 cells during erythroid differentiation. Biochim. Biophys. Acta 1263, 123–132 (1995).
  Article PubMed Google Scholar
• Santaguida, M. et al. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell 15, 341–352 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hilberg, F., Aguzzi, A., Howells, N. & Wagner, E. F. c-jun is essential for normal mouse development and hepatogenesis. Nature 365, 179–181 (1993).
  Article CAS PubMed Google Scholar
• Wo, Y., Zhu, D., Yu, Y. & Lou, Y. Involvement of NF-κB and AP1 activation in icariin promoted cardiac differentiation of mouse embryonic stem cells. Eur. J. Pharmacol. 586, 59–66 (2008).
  Article CAS PubMed Google Scholar
• Okuda, A. et al. UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells. EMBO J. 17, 2019–2032 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Rapp, U. R., Troppmair, J., Beck, T. & Birrer, M. J. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant. Oncogene 9, 3493–3498 (1994).
  CAS PubMed Google Scholar
• Mathas, S. et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-κB. EMBO J. 21, 4104–4113 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Drakos, E. et al. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders. Am. J. Surg. Pathol. 31, 447–453 (2007).
  Article PubMed Google Scholar
• Ouyang, X. et al. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res. 68, 2132–2144 (2008).
  Article CAS PubMed Google Scholar
• Mahner, S. et al. C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. Br. J. Cancer 99, 1269–1275 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Jin, S. P. et al. Prognostic significance of loss of c-fos protein in gastric carcinoma. Pathol. Oncol. Res. 13, 284–289 (2007).
  Article CAS PubMed Google Scholar
• Young, M. R. & Colburn, N. H. Fra-1 a target for cancer prevention or intervention. Gene 379, 1–11 (2006).
  Article CAS PubMed Google Scholar
• Ramirez-Carrozzi, V. & Kerppola, T. Asymmetric recognition of nonconsensus AP1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1. Mol. Cell. Biol. 23, 1737–1749 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Huguier, S., Baguet, J., Perez, S., van Dam, H. & Castellazzi, M. Transcription factor ATF2 cooperates with v-Jun to promote growth factor-independent proliferation in vitro and tumor formation in vivo. Mol. Cell. Biol. 18, 7020–7029 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• van Dam, H. et al. Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. Genes Dev. 12, 1227–1239 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Sunters, A., Thomas, D. P., Yeudall, W. A. & Grigoriadis, A. E. Accelerated cell cycle progression in osteoblasts overexpressing the c-fos proto-oncogene: induction of cyclin A and enhanced CDK2 activity. J. Biol. Chem. 279, 9882–9891 (2004).
  Article PubMed Google Scholar
• Chalmers, C. J., Gilley, R., March, H. N., Balmanno, K. & Cook, S. J. The duration of ERK1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP1. Cell Signal 19, 695–704 (2007).
  Article CAS PubMed Google Scholar
• De Cesare, D. et al. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene 11, 365–376 (1995).
  CAS PubMed Google Scholar
• Lemaigre, F. P., Ace, C. I. & Green, M. R. The cAMP response element binding protein, CREB, is a potent inhibitor of diverse transcriptional activators. Nucleic Acids Res. 21, 2907–2911 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Rutberg, S. E. et al. CRE DNA binding proteins bind to the AP1 target sequence and suppress AP1 transcriptional activity in mouse keratinocytes. Oncogene 18, 1569–1579 (1999).
  Article CAS PubMed Google Scholar
• Chiu, R., Angel, P. & Karin, M. JunB differs in its biological properties from, and is a negative regulator of c-Jun. Cell 59, 979–986 (1989).
  Article CAS PubMed Google Scholar
• Mechta, F., Lallemand, D., Pfarr, C. M. & Yaniv, M. Transformation by ras modifies AP1 composition and activity. Oncogene 14, 837–847 (1997).
  Article CAS PubMed Google Scholar
• Flint, K. J. & Jones, N. C. Differential regulation of three members of the ATF/CREB family of DNA-binding proteins. Oncogene 6, 2019–2026 (1991).
  CAS PubMed Google Scholar
• Hagmeyer, B. M., Angel, P. & van Dam, H. Modulation of AP1/ATF transcription factor activity by the adenovirus-E1A oncogene products. Bioessays 17, 621–629 (1995).
  Article CAS PubMed Google Scholar
• Pospelova, T. V. et al. E1A+ cHa-ras transformed rat embryo fibroblast cells are characterized by high and constitutive DNA binding activities of AP1 dimers with significantly altered composition. Gene Expr 8, 19–32 (1999).
  CAS PubMed Google Scholar
• Abdel-Hafiz, H. A., Chen, C. Y., Marcell, T., Kroll, D. J. & Hoeffler, J. P. Structural determinants outside of the leucine zipper influence the interactions of CREB and ATF-2: interaction of CREB with ATF-2 blocks E1a-ATF-2 complex formation. Oncogene 8, 1161–1174 (1993).
  CAS PubMed Google Scholar
• Chinenov, Y. & Kerppola, T. K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20, 2438–2452 (2001).
  Article CAS PubMed Google Scholar
• Kara, C. J., Liou, H. C., Ivashkiv, L. B. & Glimcher, L. H. A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. Mol. Cell. Biol. 10, 1347–1357 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Georgopoulos, K., Morgan, B. A. & Moore, D. D. Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer. Mol. Cell. Biol. 12, 747–757 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Bailey, J. & Europe-Finner, G. N. Identification of human myometrial target genes of the c-Jun NH2-terminal kinase (JNK) pathway: the role of activating transcription factor 2 (ATF2) and a novel spliced isoform ATF2-small. J. Mol. Endocrinol. 34, 19–35 (2005).
  Article CAS PubMed Google Scholar
• Ransone, L. J. & Verma, I. M. Nuclear proto-oncogenes fos and jun. Annu. Rev. Cell Biol. 6, 539–557 (1990).
  Article CAS PubMed Google Scholar
• Wei, W., Jin, J., Schlisio, S., Harper, J. W. & Kaelin, J. W. G. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8, 25–33 (2005).
  Article CAS PubMed Google Scholar
• Huang, C. C. et al. Calcineurin-mediated dephosphorylation of c-Jun Ser-243 is required for c-Jun protein stability and cell transformation. Oncogene 27, 2422–2429 (2007).
  Article PubMed CAS Google Scholar
• Wang, Y.-N., Chen, Y.-J. & Chang, W.-C. Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression. Mol. Pharmacol. 69, 85–98 (2006).
  Article CAS PubMed Google Scholar
• Wertz, I. E. et al. Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 303, 1371–1374 (2004).
  Article CAS PubMed Google Scholar
• Szabo, E., Riffe, M. E., Steinberg, S. M., Birrer, M. J. & Linnoila, R. I. Altered cJun expression: an early event in human lung carcinogenesis. Cancer Res. 56, 305–315 (1996).
  CAS PubMed Google Scholar
• Rangatia, J. et al. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPα DNA binding via leucine zipper domain interaction. Oncogene 22, 4760–4764 (2003).
  Article CAS PubMed Google Scholar
• Zhang, W., Hart, J., McLeod, H. L. & Wang, H. L. Differential expression of the AP1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. Am. J. Clin. Path. 124, 11–19 (2005).
  Article CAS PubMed Google Scholar
• Tessari, G. et al. The expression of proto-oncogene c-jun in human pancreatic cancer. Anticancer Res. 19, 863–867 (1999).
  CAS PubMed Google Scholar
• Acay, R. R., Santos, E.d. & Machado de Sousa, S. O. Correlation between c-Jun and human papillomavirus in oral premalignant and malignant lesions. Oral Oncology 44, 698–702 (2008).
  Article CAS PubMed Google Scholar
• Assimakopoulou, M. & Varakis, J. AP1 and heat shock protein 27 expression in human astrocytomas. J. Cancer Res. Clin. Oncol. 127, 727–732 (2001).
  CAS PubMed Google Scholar
• Papachristou, D. J., Batistatou, A., Sykiotis, G. P., Varakis, I. & Papavassiliou, A. G. Activation of the JNK-AP1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 32, 364–371 (2003).
  Article CAS PubMed Google Scholar
• Assimakopoulou, M., Kondyli, M., Gatzounis, G., Maraziotis, T. & Varakis, J. Neurotrophin receptors expression and JNK pathway activation in human astrocytomas. BMC Cancer 7, 202 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Langer, S. et al. Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters. Eur. J. Gynaecol Oncol. 27, 345–352 (2006).
  CAS PubMed Google Scholar
• Mao, X. & Orchard, G. Abnormal AP1 protein expression in primary cutaneous B-cell lymphomas. Br. J. Dermatol. 159, 145–151 (2008).
  Article CAS PubMed Google Scholar
• Wang, H., Birkenbach, M. & Hart, J. Expression of Jun family members in human colorectal adenocarcinoma. Carcinogenesis 21, 1313–1317 (2000).
  Article CAS PubMed Google Scholar
• Linardopoulos, S. et al. Human lung and bladder carcinoma tumors as compared to their adjacent normal tissue have elevated AP1 activity associated with the retinoblastoma gene promoter. Anticancer Res. 13, 257–262 (1993).
  CAS PubMed Google Scholar
• Bamberger, A. M., Milde-Langosch, K., Rossing, E., Goemann, C. & Loning, T. Expression pattern of the AP1 family in endometrial cancer: correlations with cell cycle regulators. J. Cancer Res. Clin. Oncol. 127, 545–550 (2001).
  Article CAS PubMed Google Scholar
• Prusty, B. K. & Das, B. C. Constitutive activation of transcription factor AP1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP1 activity in HeLa cells by curcumin. Int. J. Cancer 113, 951–960 (2005).
  Article CAS PubMed Google Scholar
• Cirillo, G. et al. Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate. Mol. Cell. Biol. 19, 6240–6252 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Lin, D. W. et al. Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2. J. Biol. Chem. 283, 15003–15014 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Read, M. A. et al. Tumor necrosis factorα-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 272, 2753–2761 (1997).
  Article CAS PubMed Google Scholar
• Herr, I. et al. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-α. Oncogene 19, 4255–4262 (2000).
  Article CAS PubMed Google Scholar
• Kool, J. et al. Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2. Oncogene 22, 4235–4242 (2003).
  Article CAS PubMed Google Scholar
• Bhat, N. R., Feinstein, D. L., Shen, Q. & Bhat, A. N. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor κB, cAMP response element-binding protein, CCAAT/enhancer-binding protein-β, and activating transcription factor-2. J. Biol. Chem. 277, 29584–29592 (2002).
  Article CAS PubMed Google Scholar
• Penix, L. A. et al. The proximal regulatory element of the interferon-γ promoter mediates selective expression in T cells. J. Biol. Chem. 271, 31964–31972 (1996).
  Article CAS PubMed Google Scholar
• Chen, K. D., Hung., J. J., Huang, H. L., Chang, M. D. & Lai, Y. K. Rapid induction of the Grp78 gene by cooperative actions of okadaic acid and heat-shock in 9L rat brain tumor cells — involvement of a cAMP responsive element-like promoter sequence and a protein kinase A signaling pathway. Eur. J. Biochem. 248, 120–129 (1997).
  Article CAS PubMed Google Scholar
• Suzuki, T., Yamakuni, T., Hagiwara, M. & Ichinose, H. Identification of ATF-2 as a transcriptional regulator for the tyrosine hydroxylase gene. J. Biol. Chem. 277, 40768–40774 (2002).
  Article CAS PubMed Google Scholar
• Akimoto, T. et al. Exercise stimulates Pgc-1α transcription in skeletal muscle through activation of the p38 MAPK pathway. J. Biol. Chem. 280, 19587–19593 (2005).
  Article CAS PubMed Google Scholar
• Kawasaki, H. et al. p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. Genes Dev. 12, 233–45 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, J. Y. et al. The JNK/AP1/ATF2 pathway is involved in H2O2-induced acetylcholinesterase expression during apoptosis. Cell. Mol. Life Sci. 65, 1435–1445 (2008).
  Article CAS PubMed Google Scholar